Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9428 USD | +2.86% | +3.25% | -32.88% |
May. 09 | Oppenheimer Adjusts Seres Therapeutics Price Target to $4 From $5, Maintains Outperform Rating | MT |
May. 09 | Chardan Adjusts Price Target on Seres Therapeutics to $6 From $8, Keeps Buy Rating | MT |